Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

The efficacy and safety of bevacizumab with modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion (mIFL) in the first-line treatment of metastatic colorectal cancer (mCRC) has not been well evaluated in randomized clinical trials in Chinese patients. We conducted a phrase II...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Guan, Zhong-Zhen, Xu, Jian-Ming, Luo, Rong-Cheng, Feng, Feng-Yi, Wang, Li-Wei, Shen, Lin, Yu, Shi-Ying, Ba, Yi, Liang, Jun, Wang, Dong, Qin, Shu-Kui, Wang, Jie-Jun, He, Jing, Qi, Chuan, Xu, Rui-Hua
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Sun Yat-sen University Cancer Center 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012268/
https://ncbi.nlm.nih.gov/pubmed/21959045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.011.10188
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak